The Anondita Medicare Ltd. IPO opened for subscription on 22nd August 2025, and investor interest has been buzzing with strong retail participation and a healthy Grey Market Premium (GMP). The Noida-based company, known for its COBRA brand of condoms, is looking to raise ₹69.5 crore through a fresh issue of shares.
The IPO is already showing signs of robust demand with full subscription on Day 1 itself. Here’s a detailed breakdown of the IPO, financials, and what investors should know.
📊 IPO Details
- Issue Size: ₹69.5 crore (47.93 lakh equity shares)
- Price Band: ₹137 – ₹145 per share
- Lot Size: 1,000 shares (Investment of ₹1.37 – ₹1.45 lakh per lot)
- Subscription Period: August 22 – August 26, 2025
- Allotment Finalization: August 28, 2025
- Refunds & Demat Credit: August 29, 2025
- Listing Date: September 1, 2025 (NSE SME platform)
🏭 Company Overview
- Business: Manufacturer of male condoms under the COBRA brand
- Capacity: ~562 million units annually
- Exports: Southeast Asia, Africa, and Middle East
- Founded: 2024, headquartered in Noida, Uttar Pradesh
💰 Financial Performance (FY24–25)
- Revenue: ₹77.13 crore (up 66% from ₹46.56 crore)
- Profit After Tax (PAT): ₹16.42 crore (up 327% YoY)
- Strong Growth: Driven by both domestic sales and exports
🛠️ Use of IPO Proceeds
- ₹6 crore – Purchase of new machinery & equipment
- ₹35 crore – Working capital requirements
- ₹28.5 crore – General corporate purposes & acquisitions
📌 Market Impact & Investor Takeaways
✅ Strong Retail Backing: Retail investors are betting big on the IPO, reflecting confidence in the company’s growth story.
✅ High GMP Buzz: Signals potential for attractive listing gains.
⚠️ Institutional Hesitation: Lack of QIB bids could indicate cautious sentiment among big players.
✅ Robust Fundamentals: Strong revenue and PAT growth, plus export-driven expansion, make the company attractive in the healthcare and FMCG space.
📅 Key IPO Dates
| Event | Date |
|---|---|
| Subscription Opens | Aug 22, 2025 |
| Subscription Closes | Aug 26, 2025 |
| Allotment Finalization | Aug 28, 2025 |
| Refunds & Demat Credit | Aug 29, 2025 |
| Listing Date (NSE SME) | Sep 1, 2025 |
✅ Final Word for Investors:
Anondita Medicare’s IPO has gained early traction with solid retail demand and high GMP signals, making it an attractive short-term listing gain bet. However, investors should keep an eye on institutional participation and business scalability before making long-term commitments.
Subscription
| Investor | 22 Aug 2025 | 25Aug 2025 | 26Aug 2025 |
|---|---|---|---|
| Anchor | 1 | ||
| QIB | 0.11 | ||
| Non-Institutional | 1.36 | ||
| BNII | 0.93 | ||
| SNII | 2.23 | ||
| Retail | 4.54 | ||
| Total | 2.59 |
GMP Trend:
| Date | GMP |
|---|---|
| 22 Aug 2025 | ₹65(44.83%%) |
It should be noted that IPO GMP is subject to extreme volatility, so an investment decision based solely on Patel Retail IPO GMP will prove risky. Therefore, before to investing, consider all factors and make the right investment decision whether to invest in Patel Retail IPO or not.
How to Check IPO Allotment Status:
Maashitla Securites
To check IPO allotment status, follow the steps below:
- Click on the below allotment status check button.
- Select Company Name.
- Enter your PAN Number, Application Number or DP Client ID (Anyone).
- Click on Search.
NSE Website
To check IPO allotment status, follow the steps below:
- Click on the below allotment status check button.
- Select Company Name.
- Enter your PAN Number, Application Number or DP Client ID (Anyone).
- Click on Search.
BSE Webiste
To check IPO allotment status, follow the steps below:
- Click on the below allotment status check button.
- Select Company Name.
- Enter your PAN Number, Application Number or DP Client ID (Anyone).
- Click on Search.
📌 Stock Market Disclaimer
- Disclaimer: This post is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy/sell any stock or share. Investing in the stock market involves risk. Past performance is not indicative of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.
- The information provided on this platform is for educational and informational purposes only. It should not be considered as investment advice, stock recommendations, or financial guidance.
- ⚠️ Stock Market Investments
- Investing in equities, derivatives, mutual funds, and other financial instruments involves market risks, volatility, and the possibility of capital loss.
- Past performance of stocks or indices is not indicative of future returns.
- Always conduct your own research or consult a SEBI-registered financial advisor before making investment decisions.
- ⚠️ IPO (Initial Public Offerings)
- IPO details, issue size, subscription data, and allotment status shared here are based on publicly available information from company filings, stock exchanges, and merchant bankers.
- Investing in IPOs carries risks including listing volatility, business uncertainties, and sector performance dependency.
- Neither acceptance of applications nor allotment guarantees profits. Investors should evaluate their risk appetite before subscribing.
- ⚠️ GMP (Grey Market Premium)
- Grey Market Premium (GMP) is an unofficial and unregulated indicator of expected IPO listing price.
- GMP data is collected from market observers and informal trading circles; it does not have any legal or SEBI recognition.
- GMP values are highly speculative and may differ significantly from actual listing prices. Investors should not rely solely on GMP while taking investment decisions.
- ✅ General Advisory
- We do not provide any buy/sell/hold recommendations.
- Readers and investors are solely responsible for their investment actions and decisions.
- This platform, its authors, and affiliates are not liable for any direct or indirect financial loss arising from the use of this information.
- 🔒 Always invest responsibly and diversify your portfolio.
